WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

FORMULATION, CHARACTERIZATION AND IN VIVO EVALUATION OF CARBOHYDRATE STABILIZED CERAMIC NANOPARTICLES OF LORNOXICAM

S. C. Mahajan*, D. B. Bhavsar and Dr. A. A. Phatak

ABSTRACT

The present work involves formulation and characterization of carbohydrate coated ceramic nanoparticles of hydrophobic drug lornoxicam to provide sustained release and improved efficacy of drug. Ceramic nanocarriers were synthesized using colloidal precipitation method. The prepared ceramic nanoparticles were characterized for various parameters such as percentage entrapment efficiency (% EE), particle size, surface morphology, zeta potential, powder X-ray diffraction (powder XRD) and differential scanning calorimetry (DSC). The nanoparticles were found nearly spherical in shape with 189.34 nm particle size and about 72.24% of entrapped drug. DSC analysis confirmed the complete entrapment of drug in ceramic nanoparticles and powder XRD results showed little decrease in the crystalline nature of drug when entrapped in ceramic nanocarriers. In vitro drug release study compared the release of lornoxicam from ceramic nanoparticles was compared with lornoxicam solution and marketed formulation. The result confirmed proved the sustained release of lornoxicam from ceramic nanoparticles following Peppas model for release kinetics. The in vivo anti-inflammatory activity of the formulation was studied by using Rat Paw Edema method and was found to be substantially better,when compared with the pure drug. The formulation was also found to be stable for 3 months under accelerated stability conditions.

Keywords: Lornoxicam, ceramic nanoparticles, colloidal precipitation, calcium phosphate, cellobiose, anti-inflammatory activity.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More